Praj Industries Ltd — Q4 FY26 earnings call
Summary generated by AI from the official transcript Praj Industries Ltd filed with BSE on 03 Jun 2026. Every statement cites a verbatim quote from that document — open any citation to read it. This is a record of what management said, not a recommendation. How we check these summaries
The short read
Praj Industries reported consolidated income from operations of Rs 8,445 million in Q4 FY26, roughly flat versus Rs 8,598 million a year earlier, while profit after tax fell to Rs 116 million from Rs 398 million in the prior year period. Management attributed the margin pressure to raw material cost escalation, site execution delays, and continued investment in the Praj GenX facility, and said some order finalizations were deferred due to raw material price uncertainty. The company also discussed regulatory developments around higher ethanol blending mandates, new fuel specifications for E22 through E100, and progress in bio-isobutanol, SAF, CBG, and data center cooling opportunities.
Numbers mentioned
Consolidated income from operations: Rs. 8,445 million (Q4 FY26)
p. 5
“The consolidated income from operations stood at Rs. 8,445 million in Q4 FY '26 as compared to Rs. 8,598 million in Q4 '25.”
Sachin Raole, page 5 of the filed PDF · View the filing
Profit before tax before exceptional item: Rs. 15.4 million (Q4 FY26)
p. 5
“Profit before tax before exceptional item for the quarter stood at Rs. 15.4 million as compared to Rs. 582.5 million in the corresponding period last year.”
Sachin Raole, page 5 of the filed PDF · View the filing
Profit after tax: Rs. 116 million (Q4 FY26)
p. 5
“Profit after tax stood at Rs. 116 million in Q4 as compared to Rs. 398 million in Q4 of the last year.”
Sachin Raole, page 5 of the filed PDF · View the filing
Income from operations: Rs. 31,679 million (FY26)
p. 6
“For the full year ended March 31, 2026, income from operations stood at Rs. 31,679 million as against Rs. 32,280 million in FY '25.”
Sachin Raole, page 6 of the filed PDF · View the filing
PBT: Rs. 763 million (FY26)
p. 6
“PBT stood at Rs. 763 million as against Rs. 2,704 million in FY '25.”
Sachin Raole, page 6 of the filed PDF · View the filing
PAT: Rs. 238 million (FY26)
p. 6
“PAT for 2026 came in at Rs. 238 million as against Rs. 289 million in FY '25.”
Sachin Raole, page 6 of the filed PDF · View the filing
Export revenue share: 36% (FY26)
p. 6
“Export revenues accounted for 36% for FY '26.”
Sachin Raole, page 6 of the filed PDF · View the filing
Order intake: Rs. 6,580 million (Q4 FY26)
p. 6
“The order intake during the quarter was Rs. 6,580 million with 79% from domestic market and of the total order intake 86% came from bioenergy, 2% from engineering and balance 12% from PHS business.”
Sachin Raole, page 6 of the filed PDF · View the filing
Order backlog: Rs. 43,050 million (As of March 2026)
p. 6
“The order backlog as of March 26 stood at Rs. 43,050 million comprising 66% of domestic order with 78% from bioenergy, 16% from engineering and balance 5% from PHS.”
Sachin Raole, page 6 of the filed PDF · View the filing
Cash in hand: Rs. 6.12 billion (As of March 31, 2026)
p. 6
“Cash in hand as on 31st March 2026 stood at Rs. 6.12 billion.”
Sachin Raole, page 6 of the filed PDF · View the filing
Final dividend: Rs. 3.6 per equity share (FY26)
p. 6
“The Board of Directors proposed a final dividend of Rs. 3.6 per equity share at the rate of 180% of the face value of Rs. 2 per equity share for the financial year ended 31st March 2026”
Sachin Raole, page 6 of the filed PDF · View the filing
GenX fixed overhead run rate: Rs. 10 crores per month (FY26)
p. 10
“So, the fixed overhead run rate is still continuing at the rate of almost Rs. 10 crores per month, Amit.”
Sachin Raole, page 10 of the filed PDF · View the filing
Total R&D spend: Rs. 65-66 crores (FY26)
p. 17
“In FY '26, total spend is almost Rs. 65 crores, Rs. 66 crores.”
Sachin Raole, page 17 of the filed PDF · View the filing
Clients audited Mangalore facility: 12 to 13 (Current, vs 9 at end of Q3 FY26)
p. 12
“So, at the end of third quarter, Shailesh, it was around nine, and now we have moved almost to 12 to 13 clients who have cleared the facility for us.”
Sachin Raole, page 12 of the filed PDF · View the filing
Deferred inquiries: Rs. 300 plus crores (Q4 FY26)
p. 9
“So, it is not, I will not call it as an order. I will call it as an inquiry basket. So, this was almost Rs. 300 plus crores inquiries which we didnt finalize only because of these issues.”
Sachin Raole, page 9 of the filed PDF · View the filing
What management said it would do
A record of statements made on the call, in the words management used. Parakho does not forecast, endorse or assess them, and their presence here is not a view on whether they will happen.
Bio-IBA first order — first order · Current quarter of FY27
stated firmly by Ashish Gaikwad
p. 4
“We are expecting our first order in the current quarter of FY '27.”
Ashish Gaikwad, page 4 of the filed PDF · View the filing
E85/E100 retail outlet rollout — 150 outlets initially, scaling to 500, then 5,000 · within next month, 6-12 months, and 24 months respectively
stated firmly by Ashish Gaikwad
p. 3
“The rollout begins with 150 numbers of E85 and E100 retail outlets across Delhi, Mumbai, Pune, and Nagpur within the next month.”
Ashish Gaikwad, page 3 of the filed PDF · View the filing
GenX break-even — break-even · FY27
stated as an aspiration by Ashish Gaikwad
p. 10
“Well, yes. We would like to absorb most of the cost and the investments that we have made in GenX. In the next two or three quarters, we will have to book the orders, which we alluded to.”
Ashish Gaikwad, page 10 of the filed PDF · View the filing
Order intake run-rate — Rs. 800 crores to Rs. 900 crores
stated conditionally by Ashish Gaikwad
p. 12
“Well, I think looking at the pipeline right now, we believe so. We should be in that range typically, but as we don't want to give any forward-looking statements, that is the right ballpark that one can assume.”
Ashish Gaikwad, page 12 of the filed PDF · View the filing
Higher ethanol blending mandate notification — not longer than one year
stated as an aspiration by Ashish Gaikwad
p. 12
“We believe that it will be not longer than one year, but really to predict it in terms of exact months is difficult for us.”
Ashish Gaikwad, page 12 of the filed PDF · View the filing
SAF blending mandates — 2027
stated conditionally by Ashish Gaikwad
p. 3
“A draft policy on SAF is ready and the blending mandates are expected to come in 2027.”
Ashish Gaikwad, page 3 of the filed PDF · View the filing
Overall performance improvement — improved performance · FY27
stated as an aspiration by Ashish Gaikwad
p. 5
“However, our strong technology edge in bioenergy and advanced manufacturing capabilities in modularization will help us deliver improved performance in FY '27.”
Ashish Gaikwad, page 5 of the filed PDF · View the filing
Q&A highlights
Management's answers to analyst questions, in Parakho's words rather than a transcript. Each row names who answered and carries the verbatim quote it was drawn from.
Management said reduced ethanol plant capacity needs and heavy investment in Praj GenX over the last two and a half to three years affected profitability, with a positive uptake expected from FY27.
Answered by Ashish Gaikwad
Asked by Naveen: Why has the company underperformed in margins and profits over the past three years despite being an R&D-focused company?
p. 7
“So yes, you are right, in the last three years, there was stagnation and the profits were also affected because we were investing into Praj businesses and now we should start seeing some uptake from FY '27 onwards.”
Ashish Gaikwad, page 7 of the filed PDF · View the filing
Management explained the impact was a combination of a 3% raw material price rise offset by a 2% reduction in other expenses, with the bigger driver being cost escalation on site execution delays rather than raw material prices alone.
Answered by Sachin Raole
Asked by Aditya Mongia: How much did raw material price increases impact quarterly margins?
p. 8
“Understood. If you are asking specifically for the quarter, yes, on a consolidated basis, we have seen 3% raw material prices going up. But if you have noticed, the other expenses have come down by 2%.”
Sachin Raole, page 8 of the filed PDF · View the filing
Management said data center cooling module orders were not booked in Q4 but expects good news in Q1 FY27, alongside opportunities in LNG and oil and gas.
Answered by Ashish Gaikwad
Asked by Amit Anwani: Has the GenX order deferment happened and what is the outlook for FY27?
p. 10
“I have said that we have not booked that order in Quarter 4 of last year, but we expect some good news in the 1st Quarter of this year, FY '27.”
Ashish Gaikwad, page 10 of the filed PDF · View the filing
Management said the number rose from around nine at the end of Q3 to 12-13 currently.
Answered by Sachin Raole
Asked by Sailesh Kanani: What number of clients have audited and approved the Mangalore facility, compared to end of Q3?
p. 12
“So, at the end of third quarter, Shailesh, it was around nine, and now we have moved almost to 12 to 13 clients who have cleared the facility for us.”
Sachin Raole, page 12 of the filed PDF · View the filing
Management said execution challenges driving margin pressure are largely resolved as project cycle times shorten and focus shifts to operational excellence in FY27.
Answered by Sachin Raole
Asked by Arun Zawar: Is the worst over in terms of margins?
p. 17
“So, I think to a great extent the worst is over.”
Sachin Raole, page 17 of the filed PDF · View the filing
Management broke down total R&D spend of about Rs 65-66 crores into roughly Rs 20 crores capex and Rs 45-46 crores opex.
Answered by Sachin Raole
Asked by Arun Zawar: What was the R&D spend in FY26?
p. 17
“I am talking about R&D expenses split into two parts, where we have spent on the building of our lab, additional equipment which we have taken, worth of around Rs. 20 crores, and on the OpEx side where the demo plant is running, the people who are working in the R&D are there.”
Sachin Raole, page 17 of the filed PDF · View the filing
Risks flagged
Extended project execution cycles due to funding and other challenges
p. 4
“Our fuel ethanol projects backlog execution front; the project execution cycle continues to get extended due to funding and other challenges.”
Ashish Gaikwad, page 4 of the filed PDF · View the filing
Uncertainty in raw material costs and supply chain disruptions leading to deferred order finalizations
p. 5
“However, owing to uncertainties around raw materials costs and supply chain disruptions, we deferred the final negotiations.”
Ashish Gaikwad, page 5 of the filed PDF · View the filing
Cost escalation on site execution impacting profitability
p. 8
“More than raw material prices, Aditya, we have the cost escalation coming up in the site execution.”
Sachin Raole, page 8 of the filed PDF · View the filing
Slowdown in greenfield fuel ethanol projects domestically
p. 4
“Our 1G domestic business continued to experience a slowdown in Greenfield fuel ethanol products.”
Ashish Gaikwad, page 4 of the filed PDF · View the filing
Delays in CBG order finalization despite good inquiry pipeline
p. 4
“While there is a good inquiry pipeline for projects based on press mud and Napier grass, there are some delays in order finalization.”
Ashish Gaikwad, page 4 of the filed PDF · View the filing
Subdued investment in SAF due to delayed aviation fuel mandates
p. 15
“So, although SAF has been talked about for a while, but the investments have been a little bit subdued in the past few years, mainly because the strong mandates for using SAF in the aviation turbine fuel have been delayed.”
Ashish Gaikwad, page 15 of the filed PDF · View the filing
One-time non-business related items impacting bottom line in FY26
p. 15
“And the third thing was we did experience some one-timers which were non-business related in FY '26, and they impacted our bottom line.”
Ashish Gaikwad, page 15 of the filed PDF · View the filing
Overall external business environment expected to remain uncertain
p. 5
“Overall, we believe the external business environment is going to remain uncertain.”
Ashish Gaikwad, page 5 of the filed PDF · View the filing
Generated by claude-sonnet-5. Source: the transcript as filed with BSE. We link to the exchange's copy; we do not host transcripts. Parakho is a data and screening tool, not an investment adviser — nothing here is a recommendation to buy, sell or hold.